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The philosophy of Evidence-based 
Medicine
Michael G. Samarkos
A B S T R A C T
Evidence-based Medicine is the application of the best evidence available in the care 
of individual patients, using mathematical estimates of probability and risk. Although 
elements of EBM have appeared centuries ago, the term Evidence-based Medicine 
has been used for 10 years only.
The spread of EBM followed studies which had shown that in contemporary medicine 
a significant proportion of interventions, although they are considered as the standard 
of care, have not proven efficacy.
The two principles of EBM are that evidence alone is not enough for clinical decision 
making and that there is a hierarchy of evidence. Evidence-based medicine can be 
practiced in up to five steps i.e. formulating answerable clinical questions, search-
ing for the best available evidence, critically appraising the evidence, applying the 
evidence in clinical situations and evaluating one’s effectiveness and efficiency. One 
does not have to go through all steps in practicing EBM, e.g. there now exist the so 
called secondary publications which are systematic reviews or meta-analyses of all 
available studies on a clinical problem or journals entirely devoted in appraisal of 
original studies.
Notwithstanding the “success” of EBM there is a strong current of criticism on sub-
jects practical and philosophical alike. The strongest point against EBM however is 
that there is no evidence that practicing EBM improves patients’ outcomes.
In our opinion, EBM is a very useful instrument with wide-ranging applications in the 
practice of medicine. However EBM is neither a new scientific field nor a paradigm 
shift in contemporary medicine. As an empirical approach to clinical problems, EBM 
does not produce scientific knowledge and therefore it should not be given more room 
than it deserves, neglecting basic or clinical research.
“...between man and angel there is this difference, that an angel perceives the truth by 
simple apprehension, whereas man becomes acquainted with a simple truth by a process 
from manifold data”
Thomas Aquinas, Summa Theologica.
I N T R O D U C T I O N
The term “Evidence-based Medicine” was coined in 1992 [1], but fragments 
of EBM philosophy can be tracked down centuries before that date. Arguably the 
REVIEW
5th Department of Internal Medicine, 
Evangelismos Hospital, 45 Ipsilantou 
Str., Athens 106 76, Greece
KEY WORDS: Evidence based 
medicine, clinical epidemiology, 
biostatistics, diagnostic methods, 
clinical reasoning
HOSPITAL CHRONICLES 2006, 1(1): 27–35
Address for correspondence:
Dr M. Samarkos, MSc, MD,
5th Dept of Internal Medicine, 
Evangelismos Hospital
45 Ipsilantou Str., Athens 106 76, 
Greece
Phone: +30 210 7201830




NHS: National Health System,
RCT: Randomised controlled trials
28
HOSPITAL CHRONICLES 1(1), 2006 THE PHILOSOPHY OF EVIDENCE-BASED MEDICINE
29
most important moment in the “pre-history” of EBM is the 
publication in 1835 of a study by PCA Louis, a Paris physi-
cian, who examined the effectiveness of blood-letting for the 
treatment of pneumonia. Blood-letting was then considered 
the standard of care in pneumonia but Louis collected a vast 
amount of relevant data and after systematically studying and 
analysing them he concluded that blood-letting was absolutely 
ineffective in the treatment of pneumonia [2]. PCA Louis’ 
contribution to Clinical Epidemiology lies in that he based 
his conclusions not on the individual but on the collective 
clinical experience. A year later Louis’ study was published in 
English with an Editorial introduction noting that “…it is one 
of the most important medical works of the present century, 
marking the start of a new era in science” and that “this study 
is the first formal exposition of the results of the only true 
method of investigation in regard to the therapeutic value of 
remedial agents” [3]. However the negative comments were 
as strongly worded: “The physician called to treat a sick man 
is not an actuary advising a company to accept or deny risks, 
but someone who must deal with a specific individual at a 
vulnerable moment”.
In 1847 James Lind, a Great Britain naval officer com-
pared different treatments in 12 sailors suffering from scurvy 
and concluded that “The most sudden and visible good effects 
were perceived from the use of oranges and lemons” [4].
The establishment of the modern randomised clinical 
trial is attributed to Sir Austin Bradford Hill. The trials of 
the Medical Research Council on the use of streptomycin 
for pulmonary tuberculosis, under the guidance of Hill, have 
been regarded as the forefront of a new era in medical sci-
ence [5].
Another important date in the “pre-history” of EBM is 
the publication of the book “Effectiveness and Efficiency”, 
by A.L. Cochrane in 1972. In this book Cochrane argues for 
the establishment of an international registry of randomised 
clinical trials and the use of strict quality criteria for the evalu-
ation of clinical studies [6].
Historically EBM in its present form followed the spread 
of Clinical Epidemiology which was based on the use of epi-
demiological data in clinical decision making [7]. Despite its 
limitations Clinical Epidemiology introduced a new approach 
and motivated doctors so as to start to interpret epidemiologi-
cal data themselves.
Evidence based medicine originated in McMaster Uni-
versity in Canada and in the University of Oxford. It was 
soon spread with workshops and the publication of an array 
of books, medical journals and the appearance of web pages 
[8,9].
David Sackett, defined Evidence-based Medicine (EBM) 
as “the conscientious, explicit and judicious use of current best 
evidence in making decisions about the care of individual pa-
tients” [10]. However, because EBM employs widely numerical 
data, Greenhalgh and Donald defined it as the enhancement 
of a clinician’s traditional skills in diagnosis, treatment, pre-
vention and related areas through the systematic framing of 
relevant and answerable questions and the use of mathematical 
estimates of probability and risk [11].
At present EBM is a dominant movement in contemporary 
medicine, despite reactions and criticism.
I S  T O D A Y ’ S  M E D I C I N E  
E V I D E N C E - B A S E D ?
When someone faces the term EBM for the first time, the 
natural reaction is to ask “does this mean that the practice of 
medicine so far was not evidence-based?” Physicians collect 
information before a medical decision and are among the 
professions studying the most. No drug is given to patients 
unless there is evidence on its efficacy. Using medications 
for unlabelled use might be considered illegal. It seems that 
medicine always was evidence-based. Why all the fuss?
The answer is that unfortunately medicine was not always 
evidence-based. We could go back to previous centuries when 
blood-letting, enemas, blistering ointments, hot or cold baths 
and cupping were generally accepted treatments. This has led 
many famous physicians to a “therapeutic nihilism”. William 
Osler thought that most of the treatments in his era were more 
likely to cause harm than benefit [12].
Although today the situation is completely different, there 
are many examples that support the argument that despite 
control mechanisms, medical interventions are at least poten-
tially dangerous. Characteristic examples are the withdrawal 
from the market of widely prescribed drugs such as rofecoxib 
recently and of some statins a few years ago, because of adverse 
effects. Given the fact that all drugs have more or less frequent, 
mild or severe side effects we should be absolutely certain for 
the benefit we expect from their use [13]. However a significant 
number of physicians use drugs when the expected benefit is 
negligible. A good example is the frequent use of antibiotics for 
upper respiratory tract infections, at least in Greece, although 
the majority of these infections are viral.
There is a number of studies on the behaviour of physi-
cians, nurses and other health care workers, most of which 
have concluded that clinical decisions are not always based 
on the existing evidence. It was estimated during the 1980’s 
that only 10%-20% of the medical interventions (drugs, sur-
gical interventions, imaging studies, laboratory tests) were 
performed on the basis of sound evidence [14]. These studies 
however evaluated all existing interventions, irrespectively of 
the frequency of their use. When medical interventions were 
studied in patient series, when therefore the actual frequency 
of the use of each intervention was taken into account, it was 
found that, depending on the specialty, 60-90% of clinical de-
cisions were evidence-based [15,16]. However these numbers 
refer to departments with experience in EBM, consequently 
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it is expected that the percentage would be much lower in the 
average department or unit. A recent study in a Pulmonary 
Clinic showed that only 50% of the tests for initial diagnosis 
and 20% of tests for re-evaluation or follow-up had been 
chosen on the basis of sound evidence [17].
It is therefore obvious that for a large part, the contem-
porary “conventional” (the term is used in contrast to the 
evidence-based) medicine is not evidence-based. How then 
clinical decisions are made in conventional medicine? Physi-
cians make clinical decisions based on their clinical judgement, 
their individual experience, an article or a textbook, the patho-
physiology of the disorder or, finally, on expert opinion.
Clinical judgement is indispensable and invaluable, which-
ever way one practices medicine. However, many times clinical 
experience does not help in decision making, for example in 
the use of a new medication, in which case it is important that 
the physician is familiar with the recent developments.
D E C I S I O N  M A K I N G  B A S E D  
O N  I N D I V I D U A L  E X P E R I E N C E
Experienced physicians quite often make clinical decisions 
based on their individual experience. One antibiotic may be 
preferred over another because the second “in the physician’s 
experience” is not as effective. Although this decision might 
have been made by the physician on a background of many 
years of clinical practice, we should remember that the in-
dividual experience does not stand any comparison, either 
quantitative or qualitative, to the collective experience, as this 
is recorded in a clinical trial. A large study, such as ALLHAT 
on hypertension, can analyse tens of thousands of patients 
[19]. Who can claim that he has cared for a similar number 
of patients, even in the busiest Hypertension clinic? But even 
if somebody would, it is impossible that someone remembers 
the percentage of patients which have responded to each drug, 
the number of patients which have presented side effects or 
the number of patients with potentially confounding factors 
(eg diabetes), so that he can reach safe conclusions. Human 
memory is selective and subject to bias.
D E C I S I O N  M A K I N G  B A S E D  O N  A  S T U D Y  
O R  A  T E X T B O O K
At the other end of the spectrum is decision making 
based on the results of a single study that the physician has 
recently read, without however questioning the design and 
the methods and not having searched the literature for other 
studies addressing the same question. The problem is that, as 
we will see, the quality of evidence of a single study depends 
on many factors which we should take into account. Classic 
textbooks are necessary because they contain the background 
information for decision making, however when a particular 
clinical problem is concerned, textbooks offer general direc-
tions rather than specific solutions.
D E C I S I O N  M A K I N G  B A S E D  O N  E X P E R T  O P I N I O N
Expert opinion is expressed in publications, either reviews 
or consensus conferences, which more often than not, have not 
gone through the peer-review process. It is not unusual how-
ever that these publications have been financially supported, 
directly or indirectly, by pharmaceutical companies. Someone 
would argue that experts on a subject are more suitable to 
summarize the best evidence on a clinical problem. However 
experts, exactly because of their interest on a subject, they usu-
ally have an opinion biased by their research interests or even 
by their financial or other ties with the health care industry. 
For example in a therapeutic intervention where evidence is 
conflicting, i.e. some studies show benefit while other studies 
not, an expert who conducted a “positive” study would support 
the intervention, while an expert who conducted a “negative” 
trial would argue for the contrary. Who we are going to believe 
in this case? In fact it has been demonstrated that experts on a 
subject are less suitable to review it, in comparison with a non-
expert, who has the advantage of an unbiased opinion [20].
D E C I S I O N  M A K I N G  B A S E D  
O N  PA T H O P H Y S I O L O G Y
Traditional medical education gave a central role in patho-
physiology as a background upon which decisions were made. 
Medical students were taught mechanisms of disease and they 
were instructed to use the so called inferential reasoning to 
reach decisions, be it diagnostic or therapeutic. Indeed our 
ever increasing knowledge on the mechanisms underlying dif-
ferent disorders has led clinicians to make decisions based on 
the response expected after intervening on the mechanism 
of disease. Unfortunately as our knowledge on pathophysiol-
ogy increases we realize how complicated this is. One of the 
best examples is the cytokine network. The more we learn on 
this, the more complicated become the actions and interac-
tions of individual cytokines. This “incomplete” knowledge 
of pathophysiology can lead us to wrong decisions. Just a 
few years ago the established management of patients with 
myocardial infarction with premature ventricular beats in-
cluded the use of prophylactic antiarrhythmic medication. The 
pathophysiological basis was that by suppressing extrasystoles 
we decrease the possibility of sudden death. Clinical studies 
however have shown that in fact prophylactic antiarrhythmic 
medication did not improve survival and in some instances it 
actually increased mortality [21].
D O  W E  R E A L L Y  N E E D  
E V I D E N C E - B A S E D  M E D I C I N E ?
Even if we accept that today’s medicine is evidence-based, 
the question is if we need EBM. For what reasons do we need 
EBM?
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Canada has shown that the decision to start antihypertensive 
medication was more closely associated with the time from 
medical school graduation rather than the degree of target 
organ damage [25]. Continuous medical education tries to 
solve this problem but it does not seem to be effective [26]. 
Continuous medical education especially in didactic form 
(lectures and seminars) although increases the knowledge of 
physicians does not change their clinical behaviour neither im-
proves patient outcomes [27]. Evidence-based medicine tries 
to solve the above problems suggesting a different approach 
in clinical training [3]. This approach includes the training of 
physicians in formulating their clinical questions, in searching 
for the best evidence, in evaluating the evidence and finally in 
applying it where appropriate. The practice of the above was 
so far from difficult to impossible. However the development 
of informatics gave the appropriate tools so that literature 
searching is now fast and can be performed from doctor’s of-
fices. At the same time databases were created which contain 
randomised clinical trials or systematic reviews (e.g. Cochrane 
Library), and several “secondary” journals were published 
(journals critically reviewing the literature). These develop-
ments made it possible to practice EBM in the restricted time 
available in clinical practice.
T H E  P R I N C I P L E S  
O F  E V I D E N C E - B A S E D  M E D I C I N E
As it has already been mentioned the principles of EBM 
are two: the first is the acceptance of the insufficiency of the 
evidence from the literature alone to support clinical decisions 
and the second is the hierarchy of evidence.
Clinical decisions cannot be based solely only on evidence. 
Medicine is practiced in specific patients and in a particular 
social frame, not in an abstract environment. Therefore medi-
cine has to respect the values of this social frame and the pref-
erences of patients regarding their own health. Consequently 
for clinical decision making we have to take into account, 
except for the evidence from literature concerning the benefit 
and risk of an intervention, other variables such as personal 
preferences and societal cost. For example in the literature it is 
clear that colonoscopy is superior to barium enema for the di-
agnosis of colon neoplasm. However a patient may not wish to 
undergo colonoscopy because he values more the less distress 
associated with barium enema than the better performance of 
the colonoscopy. Another example is that of clopidogrel for 
ischemic stroke prevention. Clopidogrel is superior to aspirin 
in secondary stroke prevention but it is much more expensive. 
For this reason several health authorities recommend aspirin 
considering the marginal benefit of clopidogrel not worth the 
additional cost. Literature supports clopidogrel use but con-
sidering other factors, such as the distribution of the finite 
health expenditures, health authorities decide to recommend 
During the everyday practice of medicine questions arise 
and there is need for clinical information regarding diagnosis, 
treatment, prognosis, and prevention of various diseases and 
syndromes. A study in general physicians showed that for 
the management of outpatients new information is needed 
approximately twice every three patient visits, while for inpa-
tients the number is five per patient [22]. This necessary in-
formation may regard the epidemiology, pathophysiology and 
pathology of a disease or syndrome (“background” questions), 
for example what is the prevalence of disease X in individuals 
over 50 years of age? There is however another class of clinical 
questions which refer to diagnosis, treatment, prognosis or 
prevention (“foreground” questions). In the aforementioned 
study physicians reported that they answered these questions 
consulting textbooks and journals, but they managed to an-
swer only a fraction of these questions, approximately 30%. 
However, direct observation revealed that in fact physicians 
consulted their colleagues. It was estimated that a general 
physician would have changed 4 clinical decisions in a day, 
had he had available the appropriate information [22]. So 
why do clinicians not manage to answer the questions which 
arise during patient care?
One of the reasons is that physicians do not spend time to 
study for their patients. A study in Great Britain showed that 
the time spent for studying about specific patient problems 
ranged from 1-2 hours per week for medical students, to 15-60 
minutes per week for trainee doctors [10].
The second reason is the insufficiency of the conventional 
sources of information for clinicians. Medical textbooks cover 
more the “background” questions and, additionally, the infor-
mation they contain are relatively old, especially if one takes 
into account the rate medicine changes in our times. Textbooks 
are oriented in giving general directions eg on treating a dis-
order rather than answering specific treatment questions.
Finally, although medical literature contains the best 
information for someone to answer a clinical question, it is 
impossible for anyone to be absolutely up to date, because 
of the sheer volume of information. Approximately 20,000 
medical journals are published around the world and the 
MEDLINE database contains bibliographic information for 
4.600 of these journals. MEDLINE contains over 12,000,000 
citations and over 450,000 new ones are added every year 
[23]. It has been estimated that an internist in order to be up 
to date, he has to read 17 journal articles every day for every 
single day of the year.
The inability of physicians to answer the questions which 
arise during patient care has the consequence that although 
certain abilities such as diagnostic acumen and clinical judge-
ment increase over the years, the overall clinical performance 
declines, with negative influence on the quality of care the 
physician delivers. Indeed the degree of knowledge of the 
recent developments is reciprocal to the time from medical 
school graduation [24]. A study of clinical behaviour from 
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aspirin. In other words a clinical judgement is made regarding 
the cost and benefit of the intervention.
The second principle of EBM is the hierarchy of evidence. 
Evidence-based medicine defines as potential evidence “every 
empirical observation about the apparent relation between 
events” [11]. Consequently the observations of an individual 
clinician, the results of a clinical trial, even the results of an 
in vitro experiment constitute potential evidence. However 
all pieces of evidence do not have the same power. Individual 
observations are unsystematic and subject to bias while their 
reliability is undermined by the small number of patients. The 
value of experimental data is restricted by the very fact that 
they are experimental, therefore they have been obtained 
under controlled conditions, which is not certain that they 
resemble the real ones. Finally even the best designed and 
conducted randomised double blind controlled trial for the 
evaluation of a therapeutic intervention can have low power or 
be conducted in a population of patients different from ours. 
For these reasons EBM suggests that evidence should be rated 
according to its origin. The rating of evidence differs according 
to whether question regards therapy, diagnosis, prognosis or 
prevention. For example randomised clinical trials are high 
quality evidence for therapeutic interventions while when we 
evaluate diagnostic tests cohort studies are sufficient.
When therapeutic interventions are evaluated the ran-
domised controlled trials in one patient (N of 1 randomised 
controlled trial) are on the top of the hierarchy of evidence. 
In this case the patient is subjected in succession to the in-
tervention under evaluation and an alternative intervention 
(which could be placebo drug), without neither the patient 
nor the physicians knowing to which intervention the patient 
is subjected [28]. During this trial the appropriate end points 
are recorded (e.g. sings, symptoms, laboratory findings) and 
after analysis of the results it is decided to which intervention 
the patient will be subjected from then on. This sort of study 
is not always possible but when they are feasible, they consist 
the best way of establishing the effectiveness of a therapeutic 
intervention. After the N of 1 studies in the hierarchy of evi-
dence are the systematic reviews of randomised controlled 
trials, individual controlled trial, observational studies etc.
Here we have to stress two points. The first is that the 
hierarchy of evidence is not absolute but depends on differ-
ent factors such as the number of patients and the design of 
the study [29]. If for example the therapeutic effect is large 
an observational study could give evidence as strong as or 
even stronger than that of a randomised controlled trial. 
Furthermore a badly designed and executed RCT could be 
inferior to a good observational study. The second point is that 
hierarchy of evidence means that we consider the relatively 
strongest evidence available, even when this evidence is weak. 
It could be that the only evidence available is a case series; 
consequently we have to base our decisions on this evidence. 
Evidence could be weak but it almost always exists.
S T A G E S  O F  E B M
As it has already been mentioned there are 5 stages which 
someone goes through when practicing EBM: formulating 
the clinical question, searching for the evidence, evaluating 
the evidence, applying the evidence and finally evaluating his 
performance. However it is not obligatory that each clinician 
wishing to practice EBM has to go through all 5 stages himself. 
Alternatively one can search in secondary literature, which 
has already been mentioned, for evaluated evidence, or he can 
follow protocols which have been developed and evaluated 
according to the principles of EBM [11].
F O R M U L A T I N G  A N  A N S W E R A B L E  Q U E S T I O N
The first step in practicing EBM is formulating an answer-
able question [30]. Clinical questions will arise anyway during 
the practice of medicine. However to be able to proceed to the 
next steps, we have to formulate our questions. Formulating a 
question we create a framework based on which we will search 
for evidence and we will appraise the value and relevance of 
the evidence to our patient.
The first part of a formulated question is the description 
of the patient. For example male 50 year old patient with 
hypertension, 80 year old patient with class IV NYHA heart 
failure or post-menopausal woman. The second part is the 
intervention under study (e.g. drug X or diagnostic test Y) 
and the third part, which is not always necessary, is the con-
trol or comparator intervention (e.g. another drug or placebo, 
diagnostic test Z). Finally the fourth part is the outcome or 
end-point (e.g. mortality, morbidity, establishing a diagnosis). 
It is noted that formulated questions can refer to clinical ex-
amination issues, differential diagnosis, etiology of a symptom 
or syndrome, diagnosis, treatment or prognosis.
Here are some examples of formulated clinical ques-
tions:
In patients with class IV heart failure (first part – de-
scription of the patient) does the addition of spironolactone 
(second part – intervention), in comparison to standard treat-
ment (third part – comparator intervention), increase survival 
(fourth part – outcome)?
In outpatients with suspected pulmonary embolism (first 
part) does a low concentration of d-dimers as measured by 
rapid ELISA (second part) exclude pulmonary embolism 
(fourth part)?
In patients in the emergency department with possible 
pneumonia (first part) which is the diagnostic accuracy of clini-
cal examination (second part) in comparison to chest X-ray 
(third part) for the diagnosis of pneumonia (fourth part)?
S E A R C H I N G  F O R  T H E  E V I D E N C E
In our time there are multiple sources of clinical evidence. 
These are the classic textbooks, drug companies’ leaflets, 
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proceedings of medical conferences and seminars, medical 
journals and finally the internet. We have to point out that 
some of these sources do not provide reliable evidence e.g. 
the drug company leaflets for obvious reasons and a signifi-
cant part of the websites because there is no control or peer 
review on the information they contain. Additionally some 
medical journals, particularly the ones freely distributed by 
mail, contain articles that have not gone through peer review. 
Sometimes these journals are financially dependent on drug 
companies, usually indirectly in the form of advertisement 
profits. In other instances the authors might have economic 
relationships with drug companies and present selective or 
biases evidence.
The most reliable source of evidence are the peer review 
medical journals, that is journals which publish papers that 
have been evaluated by two or three reviewers. The largest 
database of medical journals is MEDLINE which has already 
been mentioned [23]. In some cases it is relatively easy to 
search evidence from MEDLINE but in others the number of 
articles is so vast that it becomes impossible to evaluate them 
all. MEDLINE is so large that special expertise is needed 
for a productive search. This is the reason that the so called 
secondary literature has developed. Secondary literature is 
represented mainly by the Cochrane Library which is a da-
tabase of systematic reviews written by the members of the 
Cochrane Collaboration as well as a large registry of clinical 
trials [31]. Another valuable secondary source of evidence is 
the half-yearly publication Clinical Evidence (BMJ Publishing 
Group) which contains appraised evidence on treatment and 
it has practically become an official publication of the British 
National Health Service (NHS). Finally there are many jour-
nals which appraise the evidence applying predefined criteria 
such as Evidence-based Medicine [32] and Journal Watch, 
while there are similar publications for medical specialties 
(e.g. Evidence-based Cardiology).
C R I T I C A L  A P P R A I S A L  O F  T H E  E V I D E N C E
It is arguably the more critical stage in practicing EBM. 
After evidence is evaluated on the basis of the hierarchy of 
evidence, it is appraised on the basis of the following ques-
tions:
Are the results of the study valid?
This question includes a series of secondary questions 
which examine whether the design and the conduct of the 
study were appropriate. The secondary questions depend on 
the kind of the clinical problem (e.g. therapeutic intervention 
or diagnostic test study). Consequently, if the study is a clini-
cal trial of a therapeutic intervention the secondary questions 
are if there was randomization, if the study was blinded, how 
many patients completed follow up, how many dropped out 
etc. If the clinical problem is the evaluation of a diagnostic test 
then the secondary questions are if the diagnostic test under 
study was compared with the reference diagnostic test (gold 
standard), if the patient cohort included a wide spectrum of 
patients etc.
Which are the results of the study?
This question refers to the quantitative evaluation of the 
results of the study. If we appraise a therapeutic study we 
should examine how large is the treatment effect, how ac-
curate is the estimation of the treatment effect (checking the 
confidence intervals) and if it is clinically relevant.
A P P LY I N G  T H E  E V I D E N C E
In the case of a therapeutic intervention the physician 
should check whether the characteristics of his/her patient 
are similar to that of the patients studied, whether the study 
examined all the important end points, the benefit of the in-
tervention compensates possible harm and the intervention 
is cost-effective.
When diagnostic tests are concerned we have to examine 
if, taking into account the evidence from history, clinical ex-
amination, laboratory tests and imaging techniques, the results 
of this test will substantially modify (increase or decrease) the 
probability of a disease, so that this diagnosis is established 
or discarded respectively.
Finally before applying the evidence, one must ask whether 
doing this is in accordance with patient’s preferences and 
values.
E VA L U A T I N G  O U R  P E R F O R M A N C E
The last but not least important step in practicing EBM 
is the evaluation of our clinical performance. Evaluating our 
performance is essential because it offers us the potential to 
trace down our mistakes, omissions or even practices which 
are not wrong but they are not the best ones. In this context, 
apart from improving health services, EBM functions as an 
educational tool. It detects our knowledge gaps and effec-
tively fills them. Clinicians are trained in a problem-manner 
rather than follow a predetermined curriculum [33]. In this 
way clinicians are always under training but they are defining 
their own objectives.
T O O L S  F O R  E V A L U A T I O N
C R I T I C I S M  F O R  E B M
As it has already been noted there is strong criticism and 
negative reactions to EBM. These include challenging its 
effectiveness, reactions for its quick spread and dominance, 
questions regarding the ethics of EBM and queries for its 
philosophical foundations [34].
Criticism for EBM could be divided into three groups. The 
first group includes all criticism towards the rapid spread of 
EBM and its “dominant” position in today’s medicine. In most 
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of these cases criticism focuses on the connections between 
EBM and health and medical authorities in defining health 
policy. This criticism is valid in the United Kingdom where 
EBM has spread widely, with the strong support of the NHS 
and the British Medical Journal, which is an official publica-
tion of the British Medical Association. Criticism focuses on 
the leading figures of EBM who are accused that they are 
self-proclaimed reformers, that they disregard every other way 
of practicing medicine, that they are detached from clinical 
practice or that they are not even physicians but epidemiolo-
gists, biostatisticians or health economists. Evidence-based 
medicine is criticized because it has been used by the NHS to 
impose preferred clinical pathways to physicians [35]. Finally 
critics point out that EBM has failed to respond to criticism 
and that there has not been a substantial discussion for the 
benefit of EBM, if there is one. However reading this kind of 
criticism the contempt against EBM is palpable and it is also 
apparent that this criticism does not point to the substance 
of EBM but to the way it is practiced. This criticism concerns 
more the individuals involved rather than the idea of EBM.
The second group includes criticism which focuses more 
on practical aspects of EBM [36]. Thus EBM is criticised 
because it denigrates clinical expertise, it ignores patient 
preferences and values, it promotes “cookbook” medicine, it 
is a cost-containment instrument, its practice is detached from 
the bedside, it restricts physicians’ autonomy, and that when 
strong evidence is lacking it leads to therapeutic nihilism [37]. 
Additionally critics point out that there is not strong evidence 
that practicing EBM improves patient care [38]. Most of the 
above criticism originated from an incomplete understanding 
of what EBM is. When one reads what EBM is, he/she un-
derstands that clinical expertise and the patient himself have 
a central role in decision making, since the physician must 
judge, based on his expertise, if the evidence from a clinical 
trial is applicable to a particular patient [1]. Following clini-
cal protocols, without taking into account the problems and 
preferences of the patient is bad EBM or is not EBM at all. 
Evidence-based medicine does not force clinicians to apply 
what is found in the literature as long as they have a different 
opinion, which is based on specific evidence. Guidelines are 
issued but as Margaret Thatcher once said “…they are exactly 
what they say, guidelines, they are not the law…” [39]. The 
argument of therapeutic nihilism reveals ignorance of the 
basics of EBM, because as evidence we could use not only 
randomised clinical trial but much less systematic observation 
as well. Evidence-based medicine ranks the evidence and uses 
the strongest. As it has already been noted, evidence could 
be weak but it almost always exists. The criticism regarding 
the cost-containment use of EBM is also very weak, as EBM 
could either lower cost (when it shows that a cheap treatment 
is as good as or better than an expensive one) or increase the 
cost (when it shows that the more expensive treatment is the 
more effective one).
The strongest point against EBM is that there is not evi-
dence that practicing it improves patient care, which is true. It 
has been shown that EBM keeps physicians more up to date in 
comparison with the conventional continuous medical educa-
tion, but this does not translate to improved patient outcomes 
[37]. This is a weak point for EBM and well designed trials 
are needed to show its effectiveness.
Finally the third group of criticisms includes questions 
of the ethical and philosophical background of EBM. This 
group of criticisms concerns problems which are somehow 
detached from clinical practice, notwithstanding especially 
important. Critics of EBM suggest that supporters of EBM 
are convinced of its effectiveness despite the lack of evidence 
on this, while at the same time they demand evidence on the 
effectiveness of other interventions [38]. The major ethical 
fault of EBM supporters is that the stand on a primary, un-
structured and instinctive feeling that their own opinion is 
“closest to truth”, which they attempt to accommodate into a 
system of knowledge [34].
Criticism from a philosophy of knowledge point of view 
concerns the fact that EBM ranks evidence from statistical 
calculations on top of the hierarchy of evidence, while it as-
signs to pathophysiology a minor role. Criticism points to the 
fact that statistics suggest an association between measures 
or events but they tell us nothing regarding a cause and effect 
relationship. However the objective of science is searching for 
this relationship, therefore EBM is not a scientific process but 
a practical procedure. Another criticism regard how innovative 
is EBM. In the philosophy of knowledge the term “paradigm 
shift” is used. This term was coined by Thomas Kuhn to de-
scribe the radical changes brought about in the framework of 
science, after a great scientific revolution [41]. Supporters of 
EBM argue that EBM is a “paradigm shift” in medicine. Crit-
ics of EBM on the contrary suggest that EBM does not change 
radically the way medicine is practiced, because medicine was 
always based on evidence, but what was lacking was a system 
of critically appraising and ranking evidence. Evidence-based 
medicine is an important advance but is not a “paradigm shift” 
in medicine [41]. One must admit that this group of criticisms is 
the hardest to confront. Indeed EBM is based on facts, which 
may have a practical value since they are the result of outcome 
studies, but for this very reason it does not offer explanations. 
Therefore EBM does not produce new scientific knowledge 
nor advances medicine; it offers a framework and the rules 
for a rational practice of medicine.
C O N C L U S I O N
Evidence-based medicine is a movement for a different 
framework in the practice of medicine. It promotes the transfer 
of the results of clinical trials to the everyday practice, taking 
into account the problems and preferences of each individual 
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patients. Evidence-based medicine should not be looked at 
as an instrument with a limited range of applications. The 
philosophy of EBM, which is essentially the search and the 
critical appraisal of evidence, permeates many aspects of the 
practice of medicine such as medical education, health policy 
and evaluation of various interventions in health. On the other 
hand EBM should be seen in the context of its limits, which 
are put by the fact that EBM is not a scientific but an empiri-
cal management of clinical problems. Thus EBM does not 
produce scientific knowledge and therefore it should not be 
given more room than it deserves, neglecting basic or clinical 
research.
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